Cat. No.: | SPODRP01654 |
Size: | |
Quantity: |
|
Pricey: | Inquiry |
Source: | Escherichia coli |
Molecular Weight: | Approximately 16.9 kDa, a single non-glycosylated polypeptide chain containing 144 amino acids. |
Purity: | > 98% by SDS-PAGE and HPLC analyses. |
Biological Activity: | Assay #1: Fully biologically active when compared to standard. The ED50 as measured in anti-viral assays using human HeLa cells infected with encephalomyocarditis (EMC) virus is 0.15-0.80 ng/mL. The specific activity of recombinant human IFN-γ is > 1.0 × 107 IU/mg, which is calibrated against rHuIFN-γ WHO International Standard (NIBSC code: 87/586). Assay #2: The ED50 as determined by a cytotoxicity assay using human MCF-7 cells is less than 14 ng/mL. |
Physical Appearance: | Sterile filtered white lyophilized (freeze-dried) powder. |
Formulation: | Lyophilized from a 0.2 µm filtered concentrated solution in PBS, 3% Trehalose, pH5.0. |
Endotoxin: | Less than 0.01 EU/µg of rHuIFN-γ GMP as determined by LAL method. |
Reconstitution: | Centrifuge the vial briefly before opening to ensure that the contents settle at the bottom. Reconstitute the vial with sterile distilled water or an aqueous buffer containing 0.1% BSA to achieve a concentration of 0.1-1.0 mg/mL. Divide the resulting stock solution into working aliquots and store them at or below -20°C. For further dilutions, use appropriate buffered solutions. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 3 months, -20 to -70°C under sterile conditions after reconstitution. |
Background: | Interferon-gamma (IFN-γ), also referred to as Type II interferon or immune interferon, is primarily produced by T-lymphocytes and natural killer cells. This cytokine has no significant genetic resemblance to IFN-β or the varying IFN-α family proteins. The mature IFN-γ exists as non-covalently linked homodimers. It's crucial to note that human IFN-γ is particularly species-specific, demonstrating biological activity only in human and primate cells. Originally, IFN-γ was identified due to its antiviral properties. However, the protein also displays antiproliferative, immunoregulatory and proinflammatory functions and thus, plays a significant role in the host defense mechanisms. IFN-γ incites the production of several other cytokines, enhances the expression of class I and II MHC antigens, Fc receptors, and leukocyte adhesion molecules. Furthermore, it modulates macrophage functional factors, impacts isotype switching, encourages the secretion of immunoglobulins by B cells, and promotes TH1 cell differentiation and expansion. |
Shipping: | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Sequence: | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFRGR RASQ |
Sterility: | Negative. |
Mycoplasma: | Negative. |
Host Cell Protein: | Less than 0.05% when tested by ELISA. |
Quality Statement: | The manufacturing and testing of these products comply with ICH Q7 guidelines. |
Host Cell DNA: | Less than 20 ng/mg when tested by qPCR. |